FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039941216> ?p ?o ?g. }

• W2039941216 endingPage "42951" @default.
• W2039941216 startingPage "42945" @default.
• W2039941216 abstract "Cathepsin D (CatD) is a lysosomal aspartic proteinase and plays an important role in the degradation of proteins and in apoptotic processes induced by oxidative stress, cytokines, and aging. All of these stimuli are potent inducers of endothelial cell apoptosis. Therefore, we investigated the role of CatD in endothelial cell apoptosis and determined the underlying mechanisms. Incubation with 100–500 μm H2O2 for 12 h induced apoptosis in endothelial cells. To determine a role for CatD, we co-incubated endothelial cells with the CatD inhibitor pepstatin A. Pepstatin A as well as genetic knock down of CatD abolished H2O2-induced apoptosis. In contrast, overexpression of CatD wild type but not a catalytically inactive mutant of CatD (CatDD295N) induced apoptosis under basal conditions. To gain insights into the underlying mechanisms, we investigated the effect of CatD on reactive oxygen species (ROS) formation. Indeed, knocking down CatD expression reduced H2O2-induced ROS formation and apoptosis. The major redox regulator in endothelial cells is thioredoxin-1 (Trx), which plays a crucial role in apoptosis inhibition. Thus, we hypothesized that CatD may alter Trx protein levels and thereby promote formation of ROS and apoptosis. Incubation with 100 μm H2O2 for 6 h decreased Trx protein levels, whereas Trx mRNA was not altered. H2O2-induced Trx degradation was inhibited by pepstatin A and genetic knock down of CatD but not by other protease inhibitors. Incubation of unstimulated cell lysates with recombinant CatD significantly reduced Trx protein levels in vitro, which was completely blocked by pepstatin A pre-incubation. Overexpression of CatD reduced Trx protein in cells. Moreover, H2O2 incubation led to a translocation of Trx to the lysosomes prior to the induction of apoptosis. Taken together, CatD induces apoptosis via degradation of Trx protein, which is an essential anti-apoptotic and reactive oxygen species scavenging protein in endothelial cells. Cathepsin D (CatD) is a lysosomal aspartic proteinase and plays an important role in the degradation of proteins and in apoptotic processes induced by oxidative stress, cytokines, and aging. All of these stimuli are potent inducers of endothelial cell apoptosis. Therefore, we investigated the role of CatD in endothelial cell apoptosis and determined the underlying mechanisms. Incubation with 100–500 μm H2O2 for 12 h induced apoptosis in endothelial cells. To determine a role for CatD, we co-incubated endothelial cells with the CatD inhibitor pepstatin A. Pepstatin A as well as genetic knock down of CatD abolished H2O2-induced apoptosis. In contrast, overexpression of CatD wild type but not a catalytically inactive mutant of CatD (CatDD295N) induced apoptosis under basal conditions. To gain insights into the underlying mechanisms, we investigated the effect of CatD on reactive oxygen species (ROS) formation. Indeed, knocking down CatD expression reduced H2O2-induced ROS formation and apoptosis. The major redox regulator in endothelial cells is thioredoxin-1 (Trx), which plays a crucial role in apoptosis inhibition. Thus, we hypothesized that CatD may alter Trx protein levels and thereby promote formation of ROS and apoptosis. Incubation with 100 μm H2O2 for 6 h decreased Trx protein levels, whereas Trx mRNA was not altered. H2O2-induced Trx degradation was inhibited by pepstatin A and genetic knock down of CatD but not by other protease inhibitors. Incubation of unstimulated cell lysates with recombinant CatD significantly reduced Trx protein levels in vitro, which was completely blocked by pepstatin A pre-incubation. Overexpression of CatD reduced Trx protein in cells. Moreover, H2O2 incubation led to a translocation of Trx to the lysosomes prior to the induction of apoptosis. Taken together, CatD induces apoptosis via degradation of Trx protein, which is an essential anti-apoptotic and reactive oxygen species scavenging protein in endothelial cells. Lysosomes contain a variety of enzymes for the degradation of proteins, nucleic acids, polysaccharides, and lipids. Among them is the family of the proteolytic enzymes, the cathepsins (1Barrett A.J. Curr. Opin Drug. Discovery Dev. 2004; 7: 334-341PubMed Google Scholar). Cathepsins are subdivided into three classes based on the active site amino acid. Cathepsins are widely distributed in normal tissues (2Reid W.A. Valler M.J. Kay J. J. Clin. Pathol. (Lond.). 1986; 39: 1323-1330Crossref PubMed Scopus (115) Google Scholar) and involved in different physiological processes (1Barrett A.J. Curr. Opin Drug. Discovery Dev. 2004; 7: 334-341PubMed Google Scholar). Several studies suggest that cathepsins are involved in the signaling pathways leading to cell death (3Leist M. Jaattela M. Cell Death Differ. 2001; 8: 324-326Crossref PubMed Scopus (179) Google Scholar, 4Salvesen G.S. J. Clin. Investig. 2001; 107: 21-22Crossref PubMed Google Scholar). Among the cathepsins, cathepsin D (CatD) 2The abbreviations used are: CatDcathepsin DROSreactive oxygen speciesTrxthioredoxin-1HUVEChuman umbilical venous endothelial cellsHEKhuman embryonic kidneyFACSfluorescence-activated cell sorter.2The abbreviations used are: CatDcathepsin DROSreactive oxygen speciesTrxthioredoxin-1HUVEChuman umbilical venous endothelial cellsHEKhuman embryonic kidneyFACSfluorescence-activated cell sorter. seems to have a pivotal role as a cell death mediator (5Jaattela M. Cande C. Kroemer G. Cell Death Differ. 2004; 11: 135-136Crossref PubMed Scopus (70) Google Scholar, 6Yin L. Stearns R. Gonzalez-Flecha B. J. Cell. Biochem. 2005; 94: 433-445Crossref PubMed Scopus (53) Google Scholar). Fibroblasts from CatD-deficient mice are more resistant to etoposide and adriamycin-induced apoptosis than fibroblasts from their wild-type littermates (7Wu G.S. Saftig P. Peters C. El-Deiry W.S. Oncogene. 1998; 16: 2177-2183Crossref PubMed Scopus (198) Google Scholar). Furthermore, microinjection of CatD induces caspase-dependent apoptosis and staurosporine-mediated apoptotic cell death by CatD-triggered cytochrome c release (8Roberg K. Kagedal K. Ollinger K. Am. J. Pathol. 2002; 161: 89-96Abstract Full Text Full Text PDF PubMed Scopus (158) Google Scholar, 9Johansson A.C. Steen H. Ollinger K. Roberg K. Cell Death Differ. 2003; 10: 1253-1259Crossref PubMed Scopus (181) Google Scholar). cathepsin D reactive oxygen species thioredoxin-1 human umbilical venous endothelial cells human embryonic kidney fluorescence-activated cell sorter. cathepsin D reactive oxygen species thioredoxin-1 human umbilical venous endothelial cells human embryonic kidney fluorescence-activated cell sorter. Reactive oxygen species (ROS), such as H2O2, induce different cellular effects depending on the concentration and cell type. Several studies have documented the involvement of oxidative stress in apoptosis induction. Upon production of high levels of ROS from exogenous or endogenous sources, the redox balance is perturbed, and cells are shifted into a state of oxidative stress (10Parman T. Wiley M.J. Wells P.G. Nat. Med. 1999; 5: 582-585Crossref PubMed Scopus (425) Google Scholar). These excessively high concentrations of ROS directly cause oxidative damage of DNA, lipids, and proteins and may impair cellular functions, which can result in apoptosis induction in severely damaged cells (11Inoue M. Sato E.F. Nishikawa M. Hiramoto K. Kashiwagi A. Utsumi K. Redox. Rep. 2004; 9: 237-247Crossref PubMed Scopus (48) Google Scholar, 12Andersen J.K. Nat. Med. 2004; 10: S18-S25Crossref PubMed Scopus (1439) Google Scholar). CatD has been implicated to be involved in oxidative stress-induced apoptotic pathways. Lysosomes, and specifically CatD, have been identified as modulators of oxidative stress-induced apoptosis in alveolar type II cells (6Yin L. Stearns R. Gonzalez-Flecha B. J. Cell. Biochem. 2005; 94: 433-445Crossref PubMed Scopus (53) Google Scholar). Moreover, stabilization of lysosomes by imidazoline protected astrocytes from oxidative stress-mediated damage (13Choi S.H. Choi D.H. Lee J.J. Park M.S. Chun B.G. Free Radic. Biol. Med. 2002; 32: 394-405Crossref PubMed Scopus (31) Google Scholar). To protect themselves from oxidative stress, cells possess a set of antioxidative enzymes, which maintain the intracellular reactive oxygen species (ROS) at appropriate levels. Among these antioxidative enzymes are superoxide dismutase and catalase (14Fujii J. Taniguchi N. Free Radic. Res. 1999; 31: 301-308Crossref PubMed Scopus (52) Google Scholar). Two other major intracellular redox systems are the thioredoxin and glutathione systems (15Holmgren A. Antioxid Redox Signal. 2000; 2: 811-820Crossref PubMed Scopus (406) Google Scholar, 16Nordberg J. Arner E.S. Free Radic. Biol. Med. 2001; 31: 1287-1312Crossref PubMed Scopus (2167) Google Scholar). The thioredoxin family includes three proteins, thioredoxin-1 (Trx), thioredoxin-2, and Sp-thioredoxin (17Taniguchi Y. Taniguchi-Ueda Y. Mori K. Yodoi J. Nucleic Acids Res. 1996; 24: 2746-2752Crossref PubMed Scopus (118) Google Scholar, 18Spyrou G. Enmark E. Miranda-Vizuete A. Gustafsson J. J. Biol. Chem. 1997; 272: 2936-2941Abstract Full Text Full Text PDF PubMed Scopus (332) Google Scholar, 19Miranda-Vizuete A. Ljung J. Damdimopoulos A.E. Gustafsson J.A. Oko R. Pelto-Huikko M. Spyrou G. J. Biol. Chem. 2001; 276: 31567-31574Abstract Full Text Full Text PDF PubMed Scopus (126) Google Scholar). They contain a conserved Cys-Gly-Pro-Cys-active site (cysteine 32 and cysteine 35 within Trx), which is essential for the redox regulatory function of thioredoxins (20Holmgren A. J. Biol. Chem. 1989; 264: 13963-13966Abstract Full Text PDF PubMed Google Scholar). Trx is ubiquitously expressed in mammalian cells, and Trx deficiency leads to a lethal phenotype (20Holmgren A. J. Biol. Chem. 1989; 264: 13963-13966Abstract Full Text PDF PubMed Google Scholar, 21Matsui M. Oshima M. Oshima H. Takaku K. Maruyama T. Yodoi J. Taketo M.M. Dev. Biol. 1996; 178: 179-185Crossref PubMed Scopus (422) Google Scholar). Recently, we demonstrated that the anti-apoptotic function of physiological concentrations of ROS is dependent on Trx expression in human umbilical venous endothelial cells (HUVEC) (22Haendeler J. Tischler V. Hoffmann J. Zeiher A.M. Dimmeler S. FEBS Lett. 2004; 577: 427-433Crossref PubMed Scopus (90) Google Scholar). Moreover, overexpression of Trx inhibited oxidative stress-induced apoptosis in different cell types, including HUVEC (23Andoh T. Chock P.B. Chiueh C.C. J. Biol. Chem. 2002; 277: 9655-9660Abstract Full Text Full Text PDF PubMed Scopus (149) Google Scholar, 24Shioji K. Kishimoto C. Nakamura H. Masutani H. Yuan Z. Oka S. Yodoi J. Circulation. 2002; 106: 1403-1409Crossref PubMed Scopus (171) Google Scholar, 25Haendeler J. Hoffmann J. Tischler V. Berk B.C. Zeiher A.M. Dimmeler S. Nat. Cell Biol. 2002; 4: 743-749Crossref PubMed Scopus (342) Google Scholar). Therefore, we investigated the functional role of CatD on apoptosis in HUVEC and the underlying mechanisms. Our results demonstrate that H2O2 induced ROS and apoptosis in HUVEC, which was completely blocked by pepstatin A, a CatD inhibitor, as well as by genetic knock-down of CatD. To gain insights into the underlying mechanisms, we investigated the effects of H2O2 on Trx expression. H2O2 reduced Trx protein expression prior to the onset of apoptosis. Trx protein was degraded by CatD in vitro and in cells. Thus, Trx degradation may contribute to CatD- and H2O2-induced apoptosis. Cell Culture—HUVEC were cultured in endothelial basal medium supplemented with hydrocortisone (1 μg/ml), bovine brain extract (12 μg/ml), gentamicin (50 μg/ml), amphotericin B (50 ng/ml), epidermal growth factor (10 ng/ml), and 10% fetal calf serum (EBM complete). After detachment with trypsin, cells were grown for at least 18 h (26Haendeler J. Weiland U. Zeiher A.M. Dimmeler S. Nitric Oxide. 1997; 1: 282-293Crossref PubMed Scopus (97) Google Scholar, 27Dimmeler S. Haendeler J. Rippmann V. Nehls M. Zeiher A.M. FEBS Lett. 1996; 399: 71-74Crossref PubMed Scopus (280) Google Scholar). Human embryonic kidney cells (HEK293) were cultured in Dulbecco's modified Eagle's basal medium with 10% heat-inactivated fetal calf serum. Plasmids—CatD was cloned out of endothelial cell-derived cDNA using the following primers: sense, 5′-GGAATTCGCCATGCAGCCCTCCAGCCTTC-3′ and antisense, 5′-CGAAGCTTGAACAAGAGGCGGGCAGCCTCG-3′ incorporating EcoRI and HindIII restriction sites. The amplified PCR product was subcloned into pcDNA3.1(–) vector containing a Myc tag (Invitrogen). The catalytically inactive mutant of CatD (CatDD295N) was generated by site-directed mutagenesis (Stratagene) of CatD. Transfection—HUVEC or HEK293 were transfected with CatD plasmid using Superfect (Qiagen) as previously described (25Haendeler J. Hoffmann J. Tischler V. Berk B.C. Zeiher A.M. Dimmeler S. Nat. Cell Biol. 2002; 4: 743-749Crossref PubMed Scopus (342) Google Scholar). Phosphorothiolated sense or antisense oligonucleotides (5 μg) corresponding to the CatD sequence (sense, 5′-ATGCAGCCCTCCAGCCTTCTGCC-3′ and antisense, 5′-GGCAGAAGGCTGGAGGGCTGCAT-3′) were transfected into HUVEC using 5 μl of Lipofectamine (Invitrogen). After 5 h, EBM complete was added to the cells, and 2 h later, the cells were incubated with H2O2 for another 18 h. Isolation of RNA and Quantitative Reverse Transcription-PCR—RNA was isolated using the triazole reagent (Invitrogen). Trx mRNA and GAPDH mRNA were quantified using the Qiagen SYBR Green kit according to the manufacturer's instructions in a light cycler (Roche Applied Science). Immunoblot—After stimulation, HUVEC were scraped off the plates and lysed in radioimmune precipitation assay buffer (50 mm Tris-HCl, pH 8.0, 150 mm NaCl, 1% Nonidet P-40, 0.5% deoxycholic acid, 0.1% sodium dodecyl sulfate). After removing cell debris (15 min, 4 °C, 20,000 × g), 60 μg of protein/slot were resolved on SDS-polyacrylamide gels and were blotted onto polyvinylidene difluoride membranes. For detection of protein expression, membranes were incubated with antibodies against Trx, anti-CatD, anti-actin, or anti-tubulin. After incubation for 2 h with the corresponding secondary antibody tagged with horseradish peroxidase, signals were detected by the enhanced chemiluminescence system (Amersham Biosciences). Immunostaining—Cells were fixed with 4% paraformaldehyde for 15 min at room temperature. After permeabilization and blocking (permeabilization solution: 3% bovine serum albumin fraction V, 0.1% Triton X-100, 5% horse serum in phosphate-buffered saline), the cells were incubated with anti-Trx antibody (1:50, BD Biosciences) overnight at 4 °C. After incubation with a fluorescein isothiocyanate-conjugated anti-mouse antibody (1:200, Jackson ImmunoResearch), the cells were incubated with an antibody against CatD (rabbit, 1:50, overnight, 4 °C, Santa Cruz Biotechnology) and with rhodamine red-conjugated Fab fragment anti-rabbit (1:300, 1 h, room temperature, Jackson ImmunoResearch, Inc.). For nuclear staining, cells were incubated with TO-PRO-3 iodide after digestion with RNase A for 15 min (1:4000, 5 min, Molecular Probes). The cells were visualized by confocal microscopy (Zeiss, LSM 510 META; objective, Plan-Apochromat 63×, 1.4 oil). Morphological Detection of Cell Death—Cells were washed with phosphate-buffered saline and fixed in 4% formaldehyde. The cells were stained with 4′,6-diamidino-phenylindole (0.2 μg/ml in 10 mm Tris-HCl, pH 7, 10 mm EDTA, 100 mm NaCl) for 30 min. Thereafter, the cells were washed with phosphate-buffered saline, and nuclear morphology was assessed by fluorescence microscopy. Alternatively, HUVEC were co-transfected with 2.25 μg of plasmid and 0.75 μg of pcDNA3.1 vector encoding for lacZ, and apoptosis was detected by counting the morphological changes of the transfected β-galactosidase-positive cells as described previously (28Dimmeler S. Haendeler J. Galle J. Zeiher A.M. Circulation. 1997; 95: 1760-1763Crossref PubMed Scopus (335) Google Scholar). Detection of Cell Death by FACS—Detection of cell death was performed by FACS analysis using annexin V-APC binding and 7-aminoactinomycin staining (Pharmingen) as previously described (25Haendeler J. Hoffmann J. Tischler V. Berk B.C. Zeiher A.M. Dimmeler S. Nat. Cell Biol. 2002; 4: 743-749Crossref PubMed Scopus (342) Google Scholar). Annexin V is a Ca2+-dependent phospholipid-binding protein that has a high affinity to phosphatidylserine, which is exposed on the cell surface of apoptotic cells. In contrast, 7-amino-actinomycin is only cell-permeable when the cell membranes are damaged, indicative of necrotic cell death. Therefore, apoptotic cells are defined as annexin V-positive, 7-amino-actinomycin-negative cells. Detection of Intracellular ROS Formation—Living cells were incubated for dye uptake with 20 μm 2′,7′-dichlorodihydrofluorescein diacetate (H2DCF-DA) for 30 min (Molecular Probes), and ROS formation was measured by analyzing the area under the curve representing the amount of ROS formation in the cells, as previously described (25Haendeler J. Hoffmann J. Tischler V. Berk B.C. Zeiher A.M. Dimmeler S. Nat. Cell Biol. 2002; 4: 743-749Crossref PubMed Scopus (342) Google Scholar). Measurement of CatD Activity—CatD activity was measured in HUVEC using a commercially available kit (Oncogene) and detected with an enzyme-linked immunosorbent assay reader at 405 nm. In Vitro Degradation of Trx by CatD—HUVEC were lysed in radioimmune precipitation assay buffer. 100 μg of lysate was incubated with recombinant CatD in 50 mm sodium citrate buffer (pH 3.3) for 30 min at 37 °C. The reaction was stopped using SDS sample dye, and the samples were loaded onto SDS-polyacrylamide gels. After transfer onto polyvinylidene difluoride membranes, human Trx and CatD protein were detected as described above. For specificity of the in vitro assay, recombinant CatD was incubated with HUVEC lysates in phosphate-buffered saline (pH 7.2), which did not result in Trx degradation as expected. Statistics—Statistical analysis was performed with Student's t test or analysis of variance followed by modified LSD (Bonferroni) test (SPSS Software). Role of CatD in Apoptosis and Endogenous ROS Formation—To address whether CatD plays a role in endothelial cell apoptosis, HUVEC were incubated with 100 and 200 μm H2O2 for 6, 12, and 18 h. H2O2 induced apoptosis in a time-dependent manner, starting at 12 h (Fig. 1A). Pre-incubation with the cell-permeable CatD inhibitor pepstatin A (10 μg/ml) inhibited H2O2- and serum deprivation-mediated apoptosis (Fig. 1B). In contrast, incubation with the proteasome complex inhibitor MG132 or with a broad spectrum cysteine inhibitor, E64c, had no protective effect on H2O2-induced apoptosis (data not shown). Next, we cloned and overexpressed either CatD wild type or a catalytically inactive mutant of CatD (CatDD295N) in HUVEC to determine the effect of CatD on basal apoptosis. As shown in Fig. 1C, CatD induced basal apoptosis in HUVEC compared with empty vector, whereas CatDD295N had no effect on apoptosis (Fig. 1D), suggesting that CatD activity is required for apoptosis induction and supporting the concept that CatD is indeed involved in the regulation of endothelial cell apoptosis. Next, we examined whether H2O2 activates CatD. Incubation with H2O2 led to a 1.7-fold increase in CatD activity in HUVEC as early as 6 h (Fig. 1E). Increase in ROS has been discussed as an important prerequisite for cathepsin D/lysosomal-dependent apoptosis induction (29Raymond M.A. Mollica L. Vigneault N. Desormeaux A. Chan J.S. Filep J.G. Hebert M.J. FASEB J. 2003; 17: 515-517Crossref PubMed Scopus (43) Google Scholar). Furthermore, Yin et al. (6Yin L. Stearns R. Gonzalez-Flecha B. J. Cell. Biochem. 2005; 94: 433-445Crossref PubMed Scopus (53) Google Scholar) demonstrate that incubation with H2O2 increases endogenous ROS formation in astrocytes, resulting in dysfunctional lysosomes and mitochondria and subsequent apoptosis induction. Because CatD overexpression enhanced apoptosis induction, we determined whether CatD plays a role in intracellular ROS formation. Indeed, knocking down CatD expression abrogated H2O2-induced intracellular ROS formation as measured by FACS analysis (Fig. 2A). Moreover, the H2O2-induced apoptosis was completely abolished in CatD antisense-treated cells (Fig. 2B). Thus, knocking down CatD expression inhibited a disturbance of the redox balance and provided protection from H2O2-induced apoptosis.FIGURE 2Knocking down CatD expression reduced H2O2-induced ROS formation and apoptosis. HUVEC were transfected with sense or antisense oligonucleotides against CatD and incubated with 200μm H2O2 for 18 h. A, intracellular ROS was measured using FACS analysis. Data are means ± S.E., n = 7; *, p < 0.01 versus CatD sense; **, p < 0.05 versus CatD sense + H2O2. B, apoptosis was measured in HUVEC by FACS analysis. Data are means ± S.E., n = 5; p < 0.05 versus CatD sense + H2O2. DCF, dichlorofluorescein.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Oxidative Stress-induced Trx Degradation—One of the most important redox regulators in HUVEC is Trx, which scavenges H2O2 in cells. Our previous studies demonstrated that overexpression of Trx inhibited H2O2-induced apoptosis in HUVEC (25Haendeler J. Hoffmann J. Tischler V. Berk B.C. Zeiher A.M. Dimmeler S. Nat. Cell Biol. 2002; 4: 743-749Crossref PubMed Scopus (342) Google Scholar). Thus, one may speculate that activation of the protease CatD by H2O2 leads to a reduction in Trx protein. To test this hypothesis, HUVEC were incubated for 6 h with H2O2, which resulted in an increase in CatD activity (Fig. 1E). Next, we measured Trx protein levels. Indeed, H2O2 treatment for 6 h decreased Trx protein levels (Fig. 3A). To exclude the influence of H2O2 on Trx mRNA, we performed a quantitative reverse transcription-PCR after incubation with 100 and 200 μm H2O2.H2O2 did not alter TRX mRNA expression (Fig. 3B). To test the causal role of CatD in Trx degradation, we next examined whether CatD antisense treatment influenced H2O2-induced Trx degradation. Indeed, degradation of Trx was completely inhibited in CatD antisense-treated HUVEC (Fig. 3C). These results were confirmed by the addition of the cell-permeable CatD inhibitor, pepstatin A. Pepstatin A pre-incubation completely blocked H2O2-induced degradation of Trx protein (Fig. 4A). To exclude that other proteases are involved in Trx degradation, we incubated HUVEC with H2O2 in the presence of different protease inhibitors. However, using the broad spectrum metalloprotease inhibitor (EDTA, 5 mm), the cysteine protease inhibitor (cell-permeable E64c, 10 μg/ml), the broad spectrum caspase inhibitor (cell-permeable benzyloxycarbonyl-VAD, 100 μm), the ubiquitin proteasome inhibitor (MG132, 40 μm), and the serine protease inhibitor (cell-permeable phenylmethylsulfonyl fluoride (2 mm)) did not inhibit H2O2-induced Trx degradation (Fig. 4B).FIGURE 4A, pepstatin A inhibited H2O2-mediated Trx protein degradation. HUVEC were incubated for 6 h with 100 μm H2O2 and pepstatin A (pep A) as indicated. Immunoblotting with an anti-Trx antibody was performed. Membranes were reprobed with an anti-tubulin antibody. A representative immunoblot is shown (left panel). The Trx/tubulin ratio was quantified by scanning densitometry using the Scion Image program (right panel). Data are means ± S.E., n = 5; *, p < 0.05 versus H2O2. B, HUVEC were incubated with H2O2 and the indicated inhibitors (EDTA, E64c, phenylmethylsulfonyl fluoride (PMSF), MG132, and benzyloxycarbonyl-VAD (ZVAD)). The Trx/tubulin ratio was quantified by scanning densitometry using the Scion Image program. Data are means ± S.E., n = 3–8). C, recombinant CatD degrades Trx in unstimulated HUVEC lysates. Unstimulated HUVEC lysates were incubated with recombinant CatD, and immunoblotting with an anti-Trx antibody was performed. Membranes were reprobed with an anti-CatD antibody. Recombinant CatD was pre-incubated with pepstatin A (pep A). A representative immunoblot is shown. D, overexpression of CatD induced Trx protein degradation. HUVEC and HEK293 were transfected with empty vector (EV) or CatD as indicated, and immunoblotting was performed with an anti-Myc or anti-CatD antibody (upper panels) and an anti-Trx antibody (middle panels). Membranes were reprobed with an anti-tubulin or anti-actin antibody (lower panels), respectively.View Large Image Figure ViewerDownload Hi-res image Download (PPT) To underscore the specific role for CatD in the process of Trx degradation, we incubated unstimulated HUVEC lysates with recombinant CatD in an acidic environment (pH 3.3) and performed immunoblots for Trx protein. Indeed, incubation of unstimulated HUVEC lysates with CatD significantly decreased Trx protein under acidic conditions (Fig. 4C; p < 0.01). Pre-incubation of recombinant CatD with pepstatin A completely reversed the degradation process (Fig. 4C). To further support the role of CatD in Trx protein degradation, we determined Trx protein levels in CatD overexpressing HUVEC. CatD overexpression resulted in a reduction of Trx protein (Fig. 4D), To further prove the effect of CatD on Trx protein expression, we used HEK293, which can be transfected with an efficiency of 95%. Indeed, CatD overexpression abrogated Trx protein expression also in HEK293 cells (Fig. 4D). Thus, the mechanism in H2O2- and CatD overexpression-induced apoptosis may require degradation of Trx. Because CatD is located in the lysosomes and Trx in the cytosol, we next sought to determine where the degradation of Trx takes place. Recent studies (5Jaattela M. Cande C. Kroemer G. Cell Death Differ. 2004; 11: 135-136Crossref PubMed Scopus (70) Google Scholar, 9Johansson A.C. Steen H. Ollinger K. Roberg K. Cell Death Differ. 2003; 10: 1253-1259Crossref PubMed Scopus (181) Google Scholar, 13Choi S.H. Choi D.H. Lee J.J. Park M.S. Chun B.G. Free Radic. Biol. Med. 2002; 32: 394-405Crossref PubMed Scopus (31) Google Scholar, 30Kagedal K. Johansson U. Ollinger K. FASEB J. 2001; 15: 1592-1594Crossref PubMed Scopus (235) Google Scholar) suggest that CatD can be released from lysosomes when the lysosomal membrane potential is disturbed and, thereby, translocates to the cytosol and may influence apoptosis pathways. Therefore, we investigated the localization of CatD and Trx after incubation with H2O2 for 6 h, which is prior to the onset of apoptosis in HUVEC (Fig. 1A). After 6 h of H2O2 incubation, we did not detect a leakage of lysosomal CatD into cytosol (data not shown). In contrast, the cytosolic Trx protein translocated from the cytosol to the lysosomes, suggesting an uptake of Trx into the lysosomes (Fig. 5). The present study demonstrated that CatD degrades Trx in vitro and in cells, which seems to be required for CatD and H2O2-induced apoptosis in HUVEC. For several years, functions of lysosomal proteases have been described as a nonspecific intracellular degradation machinery acting within the lysosomes. Likewise, lysosomes were suggested to be solely involved in necrotic and autophagic cell death and their role in apoptosis to be limited to the digestion of apoptotic bodies (31Leist M. Jaattela M. Nat. Rev. Mol. Cell Biol. 2001; 2: 589-598Crossref PubMed Scopus (1380) Google Scholar). However, the concept has been challenged by several reports. I-cell disease (mucolipidosis type II) fibroblasts, characterized by a general deficiency in lysosomal hydrolases, are partially resistant to apoptosis induced by stress agents, such as staurosporine, sphingosine, and tumor necrosis factor α (32Tardy C. Tyynela J. Hasilik A. Levade T. Andrieu-Abadie N. Cell Death Differ. 2003; 10: 1090-1100Crossref PubMed Scopus (29) Google Scholar). Likewise, apoptosis induction is reduced in CatD-deficient fibroblasts compared with cells from their wild-type littermates (7Wu G.S. Saftig P. Peters C. El-Deiry W.S. Oncogene. 1998; 16: 2177-2183Crossref PubMed Scopus (198) Google Scholar, 33Neuzil J. Zhao M. Ostermann G. Sticha M. Gellert N. Weber C. Eaton J.W. Brunk U.T. Biochem. J. 2002; 362: 709-715Crossref PubMed Scopus (109) Google Scholar). This concept is further supported by our study, demonstrating that overexpression of CatD induced apoptosis, whereas knocking down CatD expression by an antisense approach inhibited H2O2-mediated apoptosis. An impressive body of evidence now underscores a key role for lysosomes in apoptosis signaling with functional relationships and/or cross-talks with caspases. However, it is not clear what determines the relative contribution of lysosomal enzymes and caspases in the initiation and execution of apoptosis. It has been suggested that ROS generation following mitochondrial damage could act as a feedback to the lysosomes, resulting in further activation of lysosomal enzymes and lysosomal breakdown (34Zhao M. Antunes F. Eaton J.W. Brunk U.T. Eur. J. Biochem. 2003; 270: 3778-3786Crossref PubMed Scopus (255) Google Scholar, 35Cirman T. Oresic K. Mazovec G.D. Turk V. Reed J.C. Myers R.M. Salvesen G.S. Turk B. J. Biol. Chem. 2004; 279: 3578-3587Abstract Full Text Full Text PDF PubMed Scopus (414) Google Scholar), leading to a positive feedback loop and, thereby, to an exacerbation of the caspase cascade. On the other hand short term blockade of intralysosomal digestion by lysosomotropic alkalinizing agents led to an increase in lysosomal pH, consequently a decrease in intralysosomal proteolysis and intracellular ROS formation (36Yu Z. Persson H.L. Eaton J.W. Brunk U.T. Free Radic. Biol. Med. 2003; 34: 1243-1252Crossref PubMed Scopus (196) Google Scholar). This is in accordance with the data presented in this study that indicate reduced CatD expression and activity led to a decrease in ROS. Thus, one may speculate that increase in intracellular ROS may alter lysosomal activity prior to mitochondrial damage. Here, we demonstrated that one of the most important intracellular scavengers for H2O2, Trx, is translocated to the lysosomes and degraded by CatD upon exposure to H2O2 prior to the onset of apoptosis (Figs. 1A, 3A, and 5). Moreover, H2O2-induced Trx degradation occurs prior to the onset of ROS formation (6 h, 200 μm H2O2; 102 ± 11% ROS formation compared with the control). These results suggest that Trx degradation results in increased intracellular ROS formation and, thereby, may lead to lysosomal rupture, mitochondrial damage, and apoptosis induction. An important question remains: what is the trigger leading to the translocation of Trx from the cytosol to the lysosomes? Haglund et al. (37Haglund K. Sigismund S. Polo S. Szymkiewicz I. Di Fiore P.P. Dikic I. Nat. Cell Biol. 2003; 5: 461-466Crossref PubMed Scopus (653) Google Scholar) demonstrated that a prerequisite for translocation of receptor tyrosine kinases from the plasma membrane to the lysosomes is monoubiquitination of the proteins. The process of monoubiquitination is independent of the ubiquitin-proteasome complex (38Hicke L. Nat. Rev. Mol. Cell Biol. 2001; 2: 195-201Crossref PubMed Scopus (985) Google Scholar), which fits to our study presented here, demonstrating that the specific ubiquitin-proteasome complex inhibitor, MG132, did not block H2O2-mediated degradation of Trx and apoptosis. Taken together, our data suggest that translocation of Trx to the lysosomes and degradation of Trx by CatD is a prerequisite for oxidative stress-induced apoptosis induction. Moreover, lysosomal activity and, subsequently, ROS formation seem to precede caspase activation during H2O2-induced apoptosis in HUVEC. We thank Carmen Schön for expert technical assistance." @default.
• W2039941216 created "2016-06-24" @default.
• W2039941216 creator A5001520142 @default.
• W2039941216 creator A5006283225 @default.
• W2039941216 creator A5035811651 @default.
• W2039941216 creator A5056998132 @default.
• W2039941216 creator A5061907666 @default.
• W2039941216 creator A5089998359 @default.
• W2039941216 date "2005-12-01" @default.
• W2039941216 modified "2023-09-29" @default.
• W2039941216 title "Cathepsin D and H2O2 Stimulate Degradation of Thioredoxin-1" @default.
• W2039941216 cites W1497941038 @default.
• W2039941216 cites W1551392207 @default.
• W2039941216 cites W1555938743 @default.
• W2039941216 cites W1568733499 @default.
• W2039941216 cites W1963971594 @default.
• W2039941216 cites W1967391569 @default.
• W2039941216 cites W1968091674 @default.
• W2039941216 cites W1991387227 @default.
• W2039941216 cites W1993250284 @default.
• W2039941216 cites W2018692481 @default.
• W2039941216 cites W2021067833 @default.
• W2039941216 cites W2025858206 @default.
• W2039941216 cites W2028520206 @default.
• W2039941216 cites W2031727967 @default.
• W2039941216 cites W2034915619 @default.
• W2039941216 cites W2035022316 @default.
• W2039941216 cites W2037313086 @default.
• W2039941216 cites W2038108154 @default.
• W2039941216 cites W2042141266 @default.
• W2039941216 cites W2051098020 @default.
• W2039941216 cites W2051354345 @default.
• W2039941216 cites W2052488557 @default.
• W2039941216 cites W2054027791 @default.
• W2039941216 cites W2061306124 @default.
• W2039941216 cites W2063159238 @default.
• W2039941216 cites W2065577350 @default.
• W2039941216 cites W2069981583 @default.
• W2039941216 cites W2071152217 @default.
• W2039941216 cites W2075469401 @default.
• W2039941216 cites W2083500212 @default.
• W2039941216 cites W2083944684 @default.
• W2039941216 cites W2091291402 @default.
• W2039941216 cites W2110342434 @default.
• W2039941216 cites W2140663895 @default.
• W2039941216 cites W2142560484 @default.
• W2039941216 cites W2170466989 @default.
• W2039941216 cites W2330592356 @default.
• W2039941216 doi "https://doi.org/10.1074/jbc.m506985200" @default.
• W2039941216 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16263712" @default.
• W2039941216 hasPublicationYear "2005" @default.
• W2039941216 type Work @default.
• W2039941216 sameAs 2039941216 @default.
• W2039941216 citedByCount "76" @default.
• W2039941216 countsByYear W20399412162012 @default.
• W2039941216 countsByYear W20399412162013 @default.
• W2039941216 countsByYear W20399412162014 @default.
• W2039941216 countsByYear W20399412162015 @default.
• W2039941216 countsByYear W20399412162016 @default.
• W2039941216 countsByYear W20399412162017 @default.
• W2039941216 countsByYear W20399412162018 @default.
• W2039941216 countsByYear W20399412162019 @default.
• W2039941216 countsByYear W20399412162021 @default.
• W2039941216 countsByYear W20399412162022 @default.
• W2039941216 countsByYear W20399412162023 @default.
• W2039941216 crossrefType "journal-article" @default.
• W2039941216 hasAuthorship W2039941216A5001520142 @default.
• W2039941216 hasAuthorship W2039941216A5006283225 @default.
• W2039941216 hasAuthorship W2039941216A5035811651 @default.
• W2039941216 hasAuthorship W2039941216A5056998132 @default.
• W2039941216 hasAuthorship W2039941216A5061907666 @default.
• W2039941216 hasAuthorship W2039941216A5089998359 @default.
• W2039941216 hasBestOaLocation W20399412161 @default.
• W2039941216 hasConcept C151701858 @default.
• W2039941216 hasConcept C167844969 @default.
• W2039941216 hasConcept C181199279 @default.
• W2039941216 hasConcept C185592680 @default.
• W2039941216 hasConcept C2779679103 @default.
• W2039941216 hasConcept C3623737 @default.
• W2039941216 hasConcept C41008148 @default.
• W2039941216 hasConcept C55493867 @default.
• W2039941216 hasConcept C76155785 @default.
• W2039941216 hasConcept C86803240 @default.
• W2039941216 hasConcept C95444343 @default.
• W2039941216 hasConceptScore W2039941216C151701858 @default.
• W2039941216 hasConceptScore W2039941216C167844969 @default.
• W2039941216 hasConceptScore W2039941216C181199279 @default.
• W2039941216 hasConceptScore W2039941216C185592680 @default.
• W2039941216 hasConceptScore W2039941216C2779679103 @default.
• W2039941216 hasConceptScore W2039941216C3623737 @default.
• W2039941216 hasConceptScore W2039941216C41008148 @default.
• W2039941216 hasConceptScore W2039941216C55493867 @default.
• W2039941216 hasConceptScore W2039941216C76155785 @default.
• W2039941216 hasConceptScore W2039941216C86803240 @default.
• W2039941216 hasConceptScore W2039941216C95444343 @default.
• W2039941216 hasIssue "52" @default.
• W2039941216 hasLocation W20399412161 @default.
• W2039941216 hasOpenAccess W2039941216 @default.

• next